Welcome to the 22nd WCP Congress Program Scheduling
The congress will officially run on Indochina Time (GMT+07:00)
To convert the congress times to your local time Click Here
RECORDED LECTURES
Icon Legend: Pre-Recorded & Scheduled On-Demand
Filter: Plenary/Presidental Session | Courses | Special Session | State of the Art Symposia |
Interorganizational Symposia | Original Sessions | Panel Discussions
LITHIUM USE IN BIPOLAR DISORDERS
Abstract
Abstract Body
Lithium is one of the oldest and more legendary treatment options in Psychiatry, but a full systematic review of the hard evidence alone, concerning its efficacy separately for the phases and clinical facets of Bipolar disorder (BD) was lacking until recently.This speech will present such a systematic review
The PRISMA method was followed to search the MEDLINE for Randomized Controlled trials, Post-hoc analyses and Meta-analyses and review papers up to August 1st 2020, with the combination of the words ‘bipolar’, ‘manic’, ‘mania’, ‘manic depression’ and ‘manic depressive’ and ‘randomized’.
Trials and meta-analyses concerning the use of lithium either as monotherapy or in combination with other agents in adults were identified concerning acute mania (Ν=64), acute bipolar depression (Ν=78), the maintenance treatment (Ν=73) and the treatment of other issues (N=93). Treatment guidelines were also identified. Lithium is efficacious for the treatment of acute mania including concomitant psychotic symptoms. In acute bipolar depression it is efficacious only in combination with specific agents. For the maintenance phase, it is efficacious as monotherapy mainly in the prevention of manic while its efficacy for the prevention of depressive episodes is unclear. Its combinations increase its therapeutic value. It is equaly efficacious in rapid and non-rapid cycling patients, in concomitant obsessive-compulsive symptoms, alcohol and substance abuse, the neurocognitive deficit, suicidal ideation and fatigue
The current systematic review provided support for the usefulness of lithium against a broad spectrum of clinical issues in Bipolar disorder. Its efficacy is comparable to that of more recently developed agents